Animal Models of Alzheimer's Disease: Modeling Targets, Not Disease Accelerating Drug Discovery for Alzheimer's Disease: Best Practices for Preclinical Animal Studies

No abstract is available for this paper.

• Publication year

  year unknown

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Characterization of 7- and 19-month-old Tg2576 mice using multimodal in vivo imaging: limitations as a translatable model of Alzheimer's disease.

  2012cited by this paper
• Progressive neuropathology and cognitive decline in a single Arctic APP transgenic mouse model.

  2011cited by this paper
• Alzheimer's disease.

  2011cited by this paper
• Novel age-dependent learning deficits in a mouse model of Alzheimer's disease: implications for translational research.

  2011cited by this paper
• Identification of the oxidative stress proteome in the brain.

  2011cited by this paper
• 'Too much good news' - are Alzheimer mouse models trying to tell us how to prevent, not cure, Alzheimer's disease?

  2010cited by this paper
• Magnetic Resonance Imaging Detection and Time Course of Cerebral Microhemorrhages during Passive Immunotherapy in Living Amyloid Precursor Protein Transgenic Mice

  2010cited by this paper
• Publication Bias in Reports of Animal Stroke Studies Leads to Major Overstatement of Efficacy

  2010cited by this paper
• Vascular amyloid alters astrocytic water and potassium channels in mouse models and humans with Alzheimer's disease.

  2009cited by this paper
• Alzheimer's disease and retinal neurodegeneration.

  2009cited by this paper
• Alzheimer's Research & Therapy

  2009cited by this paper
• Update of the Stroke Therapy Academic Industry Roundtable Preclinical Recommendations

  2009cited by this paper
• Neurochemistry, Neuropathology, and Heredity in SAMP8: A Mouse Model of Senescence

  2009cited by this paper
• Development of semagacestat (LY450139), a functional γ-secretase inhibitor, for the treatment of Alzheimer's disease

  2009cited by this paper
• Immunotherapy, vascular pathology, and microhemorrhages in transgenic mice.

  2009cited by this paper
• Bridging the Translational Disconnect in CNS Drug Discovery

  2009cited by this paper
• Progression of Amyloid Pathology to Alzheimer's Disease Pathology in an Amyloid Precursor Protein Transgenic Mouse Model by Removal of Nitric Oxide Synthase 2

  2008cited by this paper
• Alcohol-induced retrograde memory impairment in rats: prevention by caffeine

  2008cited by this paper
• Small Molecule, Non-Peptide p75NTR Ligands Inhibit Aβ-Induced Neurodegeneration and Synaptic Impairment

  2008cited by this paper
• Design, power, and interpretation of studies in the standard murine model of ALS

  2008cited by this paper
• A Technique for Serial Collection of Cerebrospinal Fluid from the Cisterna Magna in Mouse

  2008cited by this paper
• N-Acetylaspartate in the CNS: from neurodiagnostics to neurobiology.

  2007cited by this paper
• Reproductive Biology of the Laboratory mouse

  2007cited by this paper
• The Arctic Alzheimer mutation facilitates early intraneuronal Abeta aggregation and senile plaque formation in transgenic mice.

  2006cited by this paper
• National Institute of Neurological Disorders and Stroke–Canadian Stroke Network Vascular Cognitive Impairment Harmonization Standards

  2006cited by this paper
• NO synthase 2 (NOS2) deletion promotes multiple pathologies in a mouse model of Alzheimer's disease

  2006cited by this paper
• Interrogating rodents regarding their object and spatial memory.

  2005cited by this paper
• The role of the veterinary staff in mouse breeding colony management

  2005cited by this paper
• Accelerated amyloid deposition, neurofibrillary degeneration and neuronal loss in double mutant APP/tau transgenic mice.

  2005cited by this paper
• Characterization of a double (amyloid precursor protein-tau) transgenic: tau phosphorylation and aggregation.

  2005cited by this paper
• Implanted cannula-mediated repetitive administration of Abeta25-35 into the mouse cerebral ventricle effectively impairs spatial working memory.

  2005cited by this paper
• Age-Dependent Neurofibrillary Tangle Formation, Neuron Loss, and Memory Impairment in a Mouse Model of Human Tauopathy (P301L)

  2005cited by this paper
• Changed Conformation of Mutant Tau-P301L Underlies the Moribund Tauopathy, Absent in Progressive, Nonlethal Axonopathy of Tau-4R/2N Transgenic Mice*

  2005cited by this paper
• Breeding genetically modified rodents: tips for tracking and troubleshooting reproductive performance

  2005cited by this paper
• Aggressive amyloidosis in mice expressing human amyloid peptides with the Arctic mutation

  2004cited by this paper
• Retarded Axonal Transport of R406W Mutant Tau in Transgenic Mice with a Neurodegenerative Tauopathy

  2004cited by this paper
• Current progress in beta-amyloid immunotherapy.

  2004cited by this paper
• Aβ is targeted to the vasculature in a mouse model of hereditary cerebral hemorrhage with amyloidosis

  2004cited by this paper
• Hippocampal neurons in pre-clinical Alzheimer's disease.

  2004cited by this paper
• Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction.

  2003cited by this paper
• Early-onset Amyloid Deposition and Cognitive Deficits in Transgenic Mice Expressing a Double Mutant Form of Amyloid Precursor Protein 695*

  2001cited by this paper
• FTDP-17 mutations in tau transgenic mice provoke lysosomal abnormalities and Tau filaments in forebrain.

  2001cited by this paper
• Enhanced Neurofibrillary Degeneration in Transgenic Mice Expressing Mutant Tau and APP

  2001cited by this paper
• Blockade of long-term potentiation by beta-amyloid peptides in the CA1 region of the rat hippocampus in vivo.

  2001cited by this paper
• Presenilin-1 P264L Knock-In Mutation: Differential Effects on Aβ Production, Amyloid Deposition, and Neuronal Vulnerability

  2000cited by this paper
• High-Level Neuronal Expression of Aβ1–42 in Wild-Type Human Amyloid Protein Precursor Transgenic Mice: Synaptotoxicity without Plaque Formation

  2000cited by this paper
• Overlap between pathology of Alzheimer disease and vascular dementia.

  1999cited by this paper
• Early Phenotypic Changes in Transgenic Mice That Overexpress Different Mutants of Amyloid Precursor Protein in Brain*

  1999cited by this paper
• Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes

  1998cited by this paper
• Senescence-accelerated mouse (SAM) as an animal model of senile dementia: pharmacological, neurochemical and molecular biological approach.

  1998cited by this paper
• Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins.

  1997cited by this paper
• Age-specific onset of beta-amyloid in beagle brains.

  1996cited by this paper
• Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice

  1996cited by this paper
• Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein

  1995cited by this paper
• The aged mouse as a model of cognitive decline with special emphasis on studies in NMRI mice.

  1993cited by this paper
• Animal models of normal aging: relationship between cognitive decline and markers in hippocampal circuitry.

  1993cited by this paper
• Aged Non‐Human Primates: An Animal Model of Age‐Associated Neurodegenerative Disease

  1991cited by this paper

• From consortia discovery to biotech creation: An innovative approach to next‐gen Alzheimer's drugs

  2026cites this paper
• Experimental Models and Translational Strategies in Neuroprotective Drug Development with Emphasis on Alzheimer’s Disease

  2026cites this paper
• Plasma-based strategies for systemic rejuvenation: critical perspectives on clinical translation.

  2026cites this paper
• Twenty years of therapeutic development in tauopathy mouse models: a scoping review

  2025cites this paper
• Mitochondrial haplotype and sex modulate responses to endurance exercise training.

  2025cites this paper
• Beyond Transgenic Mice: Emerging Models and Translational Strategies in Alzheimer’s Disease

  2025cites this paper
• The "five-star matrix" for patient-centric drug discovery and development in neuroscience.

  2025cites this paper
• Exploring a patient-specific in vitro pipeline for stratification and drug response prediction of microglia-based therapeutics

  2025cites this paper
• Computational insights and experimental breakthroughs in identifying next-generation acetylcholinesterase inhibitors

  2025cites this paper
• From genetic roots to recent advancements in gene therapy targeting amyloid beta in Alzheimer’s disease

  2025cites this paper
• ND‐AMD: A Web‐Based Database for Animal Models of Neurological Disease With Analysis Tools

  2025cites this paper
• A Systematic Online Living Evidence Summary of experimental Alzheimer’s disease research

  2024cites this paper
• Gene replacement‐Alzheimer's disease (GR‐AD): Modeling the genetics of human dementias in mice

  2024cites this paper
• Pharmacogenomic Strategies in Alzheimer’s Disease: An In-Depth Review

  2024cites this paper
• Renovating the Barnes maze for mouse models of Dementia with STARR FIELD: A 4-day protocol that probes learning rate, retention and cognitive flexibility

  2024cites this paper
• Meeting report of the fifth annual workshop on Principles and Techniques for Improving Preclinical to Clinical Translation in Alzheimer's Disease Research

  2024cites this paper
• Deciphering Early and Progressive Molecular Signatures in Alzheimer’s Disease through Integrated Longitudinal Proteomic and Pathway Analysis in a Rodent Model

  2024cites this paper
• Distinctive biophysical features of human cell-types: insights from studies of neurosurgically resected brain tissue

  2023cites this paper
• Meeting report of the annual workshop on Principles and Techniques for Improving Preclinical to Clinical Translation in Alzheimer's Disease research

  2023cites this paper
• Microglia: A pharmacological target for the treatment of age-related cognitive decline and Alzheimer’s disease

  2023cites this paper
• A systematic review of exercise modalities that reduce pro-inflammatory cytokines in humans and animals' models with mild cognitive impairment or dementia.

  2023cites this paper
• Transgenic amyloid precursor protein mouse models of amyloidosis. Incomplete models for Alzheimer's disease but effective predictors of anti‐amyloid therapies

  2023cites this paper
• Pharmacogenomic Approaches in Alzheimer's Disease: A Comprehensive Review

  2023cites this paper
• Mammalian Models in Alzheimer’s Research: An Update

  2023cites this paper
• STOP‐AD portal: Selecting the optimal pharmaceutical for preclinical drug testing in Alzheimer's disease

  2023cites this paper
• Enhancement of astrocytic gap junctions Connexin43 coupling can improve long‐term isoflurane anesthesia–mediated brain network abnormalities and cognitive impairment

  2022cites this paper
• Pathogenic tau recruits wild-type tau into brain inclusions and induces gut degeneration in transgenic SPAM mice

  2022cites this paper
• A unified in vitro to in vivo fluorescence lifetime screening platform yields amyloid β aggregation inhibitors

  2022cites this paper
• Age Related Weight Loss in Female 5xFAD Mice from 3 to 12 Months of Age.

  2021cites this paper
• A Paradigm Shift from DSM-5 to Research Domain Criteria: Application to Translational CNS Drug Development

  2021cites this paper
• Circulating asymmetric dimethylarginine and cognitive decline: A 4‐year follow‐up study of the 1936 Aberdeen Birth Cohort

  2020cites this paper
• Bring Back the Rat!

  2020cites this paper
• Model organism development and evaluation for late‐onset Alzheimer's disease: MODEL‐AD

  2020cites this paper
• Advance of sporadic Alzheimer's disease animal models

  2020cites this paper
• Translational animal models for Alzheimer's disease: An Alzheimer's Association Business Consortium Think Tank

  2020cites this paper
• Does Diet Have a Role in the Treatment of Alzheimer's Disease?

  2020cites this paper
• Metabolic Profiling of Female Tg2576 Mouse Brains Provides Novel Evidence Supporting Intranasal Low-Dose Pioglitazone for Long-Term Treatment at an Early Stage of Alzheimer’s Disease

  2020cites this paper
• Improving preclinical to clinical translation in Alzheimer's disease research

  2020cites this paper
• Synaptic loss and amyloid beta alterations in the rodent hippocampus induced by streptozotocin injection into the cisterna magna

  2020cites this paper
• Translational Scoring of Candidate Treatments for Alzheimer’s Disease: A Systematic Approach

  2020cites this paper
• Systematic review of guidelines for internal validity in the design, conduct and analysis of preclinical biomedical experiments involving laboratory animals

  2020cites this paper
• Hippocampal changes in inflammasomes, apoptosis, and MEMRI after radiation-induced brain injury in juvenile rats

  2020cites this paper
• Leveraging preclinical models for the development of Alzheimer disease therapeutics

  2020cites this paper
• Challenges in Alzheimer's Disease Drug Discovery and Development: The Role of Modeling, Simulation, and Open Data

  2020cites this paper
• Preclinical Models of Alzheimer's Disease: Relevance and Translational Validity

  2019cites this paper
• Université de Montréal-Thèse et mémoire

  2019cites this paper
• Factors other than hTau overexpression that contribute to tauopathy-like phenotype in rTg4510 mice

  2019cites this paper
• Evaluating Text Mining Tools to Help Improve Rigor in Research

  2019cites this paper
• Methodological standards, quality of reporting and regulatory compliance in animal research on amyotrophic lateral sclerosis: a systematic review

  2019cites this paper
• Current state of research on non‐human primate models of Alzheimer’s disease

  2019cites this paper
• Early intrathecal infusion of everolimus restores cognitive function and mood in a murine model of Alzheimer's disease

  2019cites this paper
• General Principles of Preclinical Study Design

  2019cites this paper
• Animal Models of Alzheimer's Disease

  2019cites this paper
• ARRIVE has not ARRIVEd: Support for the ARRIVE (Animal Research: Reporting of in vivo Experiments) guidelines does not improve the reporting quality of papers in animal welfare, analgesia or anesthesia

  2018cites this paper
• Complementing preclinical safety assessments through genomic analyses

  2018cites this paper
• Modeling of age-dependent disorders: relationship between the nervous and endocrine systems

  2018cites this paper
• Clinical Trials for Disease-Modifying Therapies in Alzheimer’s Disease: A Primer, Lessons Learned, and a Blueprint for the Future

  2018cites this paper
• Preclinical efficacy in therapeutic area guidelines from the U.S. Food and Drug Administration and the European Medicines Agency: a cross‐sectional study

  2018cites this paper
• Protein misfolding in neurodegenerative diseases: implications and strategies

  2017cites this paper
• 227th ENMC International Workshop:: Finalizing a plan to guarantee quality in translational research for neuromuscular diseases Heemskerk, Netherlands, 10-11 February 2017.

  2017cites this paper
• Mouse Models of Alzheimer’s Disease

  2017cites this paper
• Towards a 21st-century roadmap for biomedical research and drug discovery: consensus report and recommendations.

  2017cites this paper
• Lessons Learned from Alzheimer Disease: Clinical Trials with Negative Outcomes

  2017cites this paper
• Mitochondrial involvement in memory impairment induced by scopolamine in rats

  2017cites this paper
• Tracking progressive pathological and functional decline in the rTg4510 mouse model of tauopathy

  2017cites this paper
• EFAD transgenic mice as a human APOE relevant preclinical model of Alzheimer’s disease[S]

  2017cites this paper
• The impact of PERK on post-traumatic tauopathy in Alzheimer ’ s disease

  2017cites this paper
• Identification of changes in neuronal function as a consequence of aging and tauopathic neurodegeneration using a novel and sensitive magnetic resonance imaging approach.

  2017cites this paper
• Sex Differences in the Cognitive and Hippocampal Effects of Streptozotocin in an Animal Model of Sporadic AD

  2017cites this paper
• A Librarian’s Role in Improving Rigor in Research—AlzPED: Alzheimer’s Disease Preclinical Efficacy Database

  2017cites this paper
• Mouse models of central nervous system ageing

  2017cites this paper
• From Reproducibility to Translation in Neurodegenerative Disease.

  2017cites this paper
• New Paths Forward in Translational Medicine: Innovative Biological Models

  2017cites this paper
• The Geroscience Hypothesis: Is It Possible to Change the Rate of Aging?

  2016cites this paper
• A multifunctional therapeutic approach to disease modification in multiple familial mouse models and a novel sporadic model of Alzheimer’s disease

  2016cites this paper
• Deficits in hippocampal‐dependent transfer generalization learning accompany synaptic dysfunction in a mouse model of amyloidosis

  2016cites this paper
• PERK-opathies: An Endoplasmic Reticulum Stress Mechanism Underlying Neurodegeneration.

  2016influential citation
• BBB-Permeable, Neuroprotective, and Neurotrophic Polysaccharide, Midi-GAGR

  2016cites this paper
• MW151 Inhibited IL-1β Levels after Traumatic Brain Injury with No Effect on Microglia Physiological Responses

  2016cites this paper
• Longitudinal Characterization of [18F]-FDG and [18F]-AV45 Uptake in the Double Transgenic TASTPM Mouse Model

  2016cites this paper
• Translating the Science of Aging into Therapeutic Interventions.

  2016cites this paper
• Guidelines to improve animal study design and reproducibility for Alzheimer's disease and related dementias: For funders and researchers

  2016cites this paper
• Big data to smart data in Alzheimer's disease: The brain health modeling initiative to foster actionable knowledge

  2016cites this paper
• Screening and evaluation of natural compounds for therapeutic application in Alzheimer's disease

  2016cites this paper
• Increased Electron Paramagnetic Resonance Signal Correlates with Mitochondrial Dysfunction and Oxidative Stress in an Alzheimer’s disease Mouse Brain

  2016cites this paper
• The fornix provides multiple biomarkers to characterize circuit disruption in a mouse model of Alzheimer's disease

  2016cites this paper
• Evaluating Health Span in Preclinical Models of Aging and Disease: Guidelines, Challenges, and Opportunities for Geroscience

  2016cites this paper
• AGE-RELATED WEIGHT LOSS IN THE 5XFAD MOUSE MODEL OF ALZHEIMER’S DISEASE: A BEHAVIOURAL AND HORMONAL ANALYSIS

  2015cites this paper
• Attenuation of traumatic brain injury-induced cognitive impairment in mice by targeting increased cytokine levels with a small molecule experimental therapeutic

  2015cites this paper
• Best Practices and Standard Protocols as a Tool to Enhance Translation for Neuromuscular Disorders

  2015cites this paper
• The Future of Preclinical Animal Models in Pharmaceutical Discovery and Development

  2015cites this paper
• A meta-analysis of efficacy in pre-clinical human stem cell therapies for traumatic brain injury.

  2015cites this paper
• The problem of genotype and sex differences in life expectancy in transgenic AD mice.

  2015cites this paper
• Risk of Bias in Reports of In Vivo Research: A Focus for Improvement

  2015cites this paper
• Behavioral abnormalities in APPSwe/PS1dE9 mouse model of AD-like pathology: comparative analysis across multiple behavioral domains.

  2015cites this paper
• Characterization of Aldh2-/- mice as an age-related model of cognitive impairment and Alzheimer’s disease

  2015cites this paper
• Intracerebroventricular Streptozotocin Injections as a Model of Alzheimer’s Disease: in Search of a Relevant Mechanism

  2015cites this paper
• Ethics of Cancer Gene Transfer Clinical Research.

  2015cites this paper
• Translation of Pre-Clinical Studies into Successful Clinical Trials for Alzheimer’s Disease: What are the Roadblocks and How Can They Be Overcome?

  2015cites this paper
• Considering a new paradigm for Alzheimer's disease research.

  2014influential citation